Vaccine development and therapeutic design for 2019‐nCoV/SARS‐CoV‐2: Challenges and chances

M Ghaebi, A Osali, H Valizadeh… - Journal of cellular …, 2020 - Wiley Online Library
The ongoing outbreak of the recently emerged 2019 novel coronavirus (nCoV), which has
seriously threatened global health security, is caused by severe acute respiratory syndrome …

[HTML][HTML] Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies

GM Nitulescu, H Paunescu… - International …, 2020 - spandidos-publications.com
The major impact produced by the severe acute respiratory syndrome coronavirus 2 (SARS‑
CoV‑2) focused many researchers attention to find treatments that can suppress …

[PDF][PDF] Succinct review on biological and clinical aspects of Coronavirus disease 2019 (COVID-19)

SE Ahmadi, M Farzanehpour, AMM Fard… - Romanian Journal of …, 2022 - scumc.ro
The prevalence of coronavirus disease 2019 (COVID-19) is the third registered spillover of
an animal coronavirus to humans from the early 21st century. Coronaviruses are important …

[HTML][HTML] An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19)

A Alagheband Bahrami, A Azargoonjahromi… - Cellular & molecular …, 2022 - Springer
Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …

Potential antiviral drugs for SARS-Cov-2 treatment: preclinical findings and ongoing clinical research

S Bimonte, A Crispo, A Amore, E Celentano, A Cuomo… - in vivo, 2020 - iv.iiarjournals.org
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), initially termed 2019-new
CoV (2019-nCoV), is a novel coronavirus responsible for the severe respiratory illness …

[HTML][HTML] COVID-19: characteristics and therapeutics

R Chilamakuri, S Agarwal - Cells, 2021 - mdpi.com
Novel coronavirus (COVID-19 or 2019-nCoV or SARS-CoV-2), which suddenly emerged in
December 2019 is still haunting the entire human race and has affected not only the …

[HTML][HTML] Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials

B Deb, H Shah, S Goel - Journal of biosciences, 2020 - Springer
COVID-19 has become one of the biggest health concern, along with huge economic
burden. With no clear remedies to treat the disease, doctors are repurposing drugs like …

Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future

M Rehman, I Tauseef, B Aalia, SH Shah, M Junaid… - Future …, 2020 - Taylor & Francis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
coronavirus disease 2019. It was first reported in Wuhan, China and has since become a …

SARS-CoV-2 vaccine development: an overview and perspectives

Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …

[HTML][HTML] COVID-19 challenges and its therapeutics

SU Rehman, SU Rehman, HH Yoo - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Abstract COVID-19, an infectious disease, has emerged as one of the leading causes of
death worldwide, making it one of the severe public health issues in recent decades. nCoV …